3-hydroxyflavone has been researched along with Leukemia, Lymphocytic, Chronic, B-Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Accordi, B; Basso, G; Bresolin, S; Facco, M; Frezzato, F; Martini, V; Piazza, F; Raggi, F; Scomazzon, E; Semenzato, G; Severin, F; Trentin, L; Trimarco, V; Visentin, A | 1 |
| Everaus, H; Kasemaa, K; Sak, K | 1 |
2 other study(ies) available for 3-hydroxyflavone and Leukemia, Lymphocytic, Chronic, B-Cell
| Article | Year |
|---|---|
HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia.
Topics: Adenine; Case-Control Studies; Cell Line, Tumor; Cell Nucleus; Cell Survival; Dose-Response Relationship, Drug; Flavonoids; Flavonols; Gene Expression Regulation, Neoplastic; Heat Shock Transcription Factors; HSP70 Heat-Shock Proteins; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Molecular Targeted Therapy; Phosphatidylinositol 3-Kinases; Piperidines; Prognosis; Proteomics; Proto-Oncogene Proteins c-akt; Pyrazoles; Pyrimidines; Signal Transduction; Up-Regulation | 2019 |
Potentiation of luteolin cytotoxicity by flavonols fisetin and quercetin in human chronic lymphocytic leukemia cell lines.
Topics: Apoptosis; Caspase 3; Caspase 9; Cell Line, Tumor; Drug Synergism; Flavonoids; Flavonols; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes, Mononuclear; Luteolin; Quercetin | 2016 |